Bronchoscopie souple et antiagrégants plaquettaires : analyse du rapport bénéfices-risques

While awaiting clinical studies that will allow a better understanding of these questions, and the subsequent publication of practice guidelines, it is crucial that respiratory physicians are aware of the need, prior to FB, to enquire routinely about treatment with APAs, to identify the indication, and never to interrupt such treatment without consulting the prescriber.